NON-HODGKINS LYMPHOMA
Clinical trials for NON-HODGKINS LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKINS LYMPHOMA trials appear
Sign up with your email to follow new studies for NON-HODGKINS LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets tough blood cancers after other treatments fail
Disease control Recruiting nowThis study is testing an oral drug called nemtabrutinib in people with several types of advanced blood cancers that have come back or stopped responding to other treatments. It aims to find a safe and effective dose and see how well the drug shrinks tumors and controls the diseas…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug combo targets tough blood cancers in phase 2 trial
Disease control Recruiting nowThis study is testing two experimental drugs, APG-115 and APG-2575, either alone or together, for adults with T-cell prolymphocytic leukemia (T-PLL) or non-Hodgkin's lymphoma (NHL) that has come back or hasn't responded to prior treatment. The main goals are to find safe doses an…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC